Synergistic Zika Virus Vaccine Systems

The present inventive concept integrates the recombinant measles virus expressing Zika virus prM and E proteins with distinct technologies such as AI, IoT, blockchain, and novel materials to create more powerful and effective vaccine systems for rapid response to Zika virus outbreaks.

The original patent disclosed a recombinant measles virus expressing Zika virus prM and E proteins, but it lacked the capabilities for real-time monitoring, secure distribution, and adaptive response to outbreaks. The new inventive concept addresses these limitations by incorporating synergistic combinations of technologies to create a more comprehensive and effective vaccine system.

The new inventive concept comprises four distinct embodiments: (1) a vaccine system integrating the recombinant measles virus with an AI-powered diagnostic tool for real-time monitoring of Zika virus outbreaks; (2) a method for generating a Zika virus vaccine candidate using a mammalian expression plasmid and integrating it with a blockchain-based supply chain management system; (3) a synergistic combination of the recombinant measles virus with an IoT-enabled wearable device for real-time monitoring of vaccine efficacy and immune response; and (4) a system for predicting Zika virus outbreaks using a machine learning algorithm trained on a dataset of Zika virus genome sequences and integrating it with the recombinant measles virus for rapid vaccine development and deployment. Additionally, a novel material composition for vaccine delivery is disclosed, comprising a nanoparticle-based system for encapsulating the recombinant measles virus and integrating it with a blockchain-based tracking system.

The new claims introduce novel and non-obvious combinations of the recombinant measles virus with distinct technologies, providing a synergistic effect that enhances the effectiveness and responsiveness of the vaccine system. The inventive step lies in the integration of these technologies to create a more comprehensive and adaptive vaccine system.

Alternative embodiments of the inventive concept could include integrating the recombinant measles virus with other AI-powered tools, such as predictive analytics or natural language processing, or using different types of wearable devices or novel materials for vaccine delivery. Variations of the inventive concept could also include adapting the vaccine system for other diseases or integrating it with other healthcare systems.

The inventive concept has significant commercial potential in the vaccine and healthcare industries, particularly in regions where Zika virus outbreaks are common. The integrated vaccine system could be marketed as a comprehensive solution for rapid response to outbreaks, offering advantages in terms of real-time monitoring, secure distribution, and adaptive response.